The Central Vascular Access Device Infection Control program was developed to provide essential education regarding the prevention of bloodstream infections associated with the placement of central venous catheters.
Infection control involves the following objectives:
- Understand infections and how they occur
- Define CLABSI
- Describe institutional protocols designed to prevent infection
- Identify evidence based practices that reduce infection
This program covers infection prevention issues and bundles as described in standards, guidelines and research publications. The evidence based practices included are designed to positively affect and help reduce infection rates in all facilities.
A central line associated bloodstream infection (CLABSI) is a laboratory-confirmed bloodstream infection (BSI) of recognized pathogens in a patient who has had a central line within the 48 hour period prior to the development of the BSI and these pathogens are not related to an infection at another site. The BSI is caused by bacteria or fungal contamination that enters the bloodstream and begins to colonize. When the bacterial colonies grow large enough, pieces break off and attach themselves to different parts of the body as they travel through the bloodstream. When colonization reaches a critical level, symptoms develop that result in an infection within the body. When left untreated, these bacterial colonies eventually cause infections within the bloodstream resulting in a CLABSI.
To purchase Infection Prevention of CVADs go to https://www.piccexcellence.com/education/productpage.php?productID=93